Key result
This systematic review aimed to describe the prevalence, impact, pathophysiology, and management of depression and anxiety in patients with atrial fibrillation.
Why the study?
What is the prevalence, impact, and management of depression and anxiety in patients with atrial fibrillation?
Systematic Review
What is the prevalence, impact, and management of depression and anxiety in patients with atrial fibrillation?
This systematic review aims to describe the prevalence, impact, and management of depression and anxiety in patients with atrial fibrillation.
Mental health screening merits integration into AF care pathways; extends support for holistic management addressing psychiatric comorbidity.
Atrial fibrillation (AF) is the most commonly seen arrhythmia in clinical practice. At present, few studies have been conducted centering on depression and anxiety in AF patients. Our aim in this systematic review is to use the relevant literature to (1) describe the prevalence of depression and anxiety in AF patients, (2) assess the impact that depression and anxiety have on illness perception in patients with AF, (3) provide evidence to support a hypothetical connection between the pathophysiology of AF and depression and anxiety, (4) evaluate the benefit of treatment of AF on depression and anxiety, and (5) give insight on medically managing a patient with AF and concomitant depression and anxiety.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2013) conducted a systematic review in Atrial fibrillation with depression and anxiety. Depression and anxiety was evaluated on Prevalence, impact, pathophysiology, and management of depression and anxiety in AF patients. This systematic review aimed to describe the prevalence, impact, pathophysiology, and management of depression and anxiety in patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: